Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of the Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

This study has been completed.
Sponsor:
Collaborator:
CKD Pharmaceutical Limited
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT00947843
First received: July 25, 2009
Last updated: July 27, 2009
Last verified: July 2009